Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single Hardware Solution Utilizes Multiple Diagnostics Technologies

By LabMedica International staff writers
Posted on 09 Sep 2010
A single hardware solution utilizes multiple diagnostics technologies such as enzyme immunoassay (EIA), chemiluminescence, and multiplexing.

Called the ThunderBolt platform, the inaugural product is an EIA processor, with a completely open software design capable of programming virtually any EIA test.

These tests are widely used to detect and quantify substances such as peptides, proteins, antibodies, and hormones, and to diagnose diseases and conditions including infections, cancer, metabolic disorders, allergies, and autoimmune diseases.

In a single, easily configured run, the flexible ThunderBolt EIA processor can process multiple microtiter plates, while also running up to eight different simultaneous assays. More...
With an onboard reader, the fully automated processor offers a true walkaway solution for labs of any size.

The compact design takes up less than half the workspace of similar EIA automated processors on the market. Cost-effective operation makes the platform suitable for larger clinical laboratories, while it also provides the customizable capabilities needed in hospital or research laboratories.

Gold Standard Diagnostics, Corp. (Davis, CA, USA), a provider of laboratory diagnostics solutions, introduced the ThunderBolt platform at the 2010 Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), which was held at the Anaheim Convention Center (CA, USA) on July 25-29, 2010.

"The ThunderBolt platform represents a true innovation in automated diagnostics instrumentation and is the culmination of nearly 20 years of feedback from laboratory customers around the world,” says John Griffiths, president and CEO of Gold Standard Diagnostics. "By understanding what customers really need, we have been able to build a product that's the right blend of power, flexibility, and ease of use, all at a competitive price.”

GSD provides products, services, and consulting to the diagnostic and medical communities. The company has been creating and cost-effective diagnostics solutions for clinical and hospital laboratories since 2006.

Related Links:
Gold Standard Diagnostics, Corp.
American Association for Clinical Chemistry



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.